Featured Research

from universities, journals, and other organizations

Researchers Discover Treatment For Spinal Cord Injury Pain

Date:
November 28, 2006
Source:
American Academy of Neurology
Summary:
Spinal cord injury patients with moderate to severe nerve pain experienced less pain and in some cases no pain while taking the drug pregabalin, according to a study published in the Nov. 28, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.

Spinal cord injury patients with moderate to severe nerve pain experienced less pain and in some cases no pain while taking the drug pregabalin, according to a study published in the November 28, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.

Related Articles


"The findings are promising as spinal cord injury pain is a condition which generally responds poorly to currently available treatments," said study author Philip J. Siddall, MBBS, PhD, with Royal North Shore Hospital in Sydney, Australia.

The study, considered to be the largest randomized controlled trial of spinal cord injury patients with nerve pain, involved 137 adults in Australia over a 12-week period. Half of the group received pregabalin; the other half received a placebo.

Researchers found at the end of 12 weeks, fewer than 16 percent of patients taking pregabalin had severe pain compared with 43 percent in the placebo group. And over one-third of patients in the pregabalin group had no or mild pain.

The study also found pregabalin reduced sleep and anxiety problems compared to the placebo group.

"Pregabalin was significantly more effective in relieving pain, improving sleep, anxiety, and overall well-being in patients with spinal cord injury compared to placebo," said Siddall. "Fifty-seven percent of patients taking pregabalin said they felt better overall compared to 21 percent in the placebo group."

Siddall said the pain relief was rapid as the pregabalin group had significant pain relief after the first week of the study. The drug's most common side effects were dizziness and drowsiness.

Nerve pain is estimated to occur in up to 40 percent of people with spinal cord injury. According to the National Spinal Cord Injury Association, as many as 450,000 people in the United States have spinal cord injuries and about 11,000 people sustain new spinal cord injuries each year.

Pregabalin is currently used to treat two of the most common types of nerve pain: diabetic nerve pain and pain after shingles. The drug is manufactured by Pfizer Inc., which supported this study.

The American Academy of Neurology, an association of more than 19,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer's disease, epilepsy, Parkinson disease, and multiple sclerosis.

For more information about the American Academy of Neurology, visit http://www.aan.com.


Story Source:

The above story is based on materials provided by American Academy of Neurology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Neurology. "Researchers Discover Treatment For Spinal Cord Injury Pain." ScienceDaily. ScienceDaily, 28 November 2006. <www.sciencedaily.com/releases/2006/11/061128084522.htm>.
American Academy of Neurology. (2006, November 28). Researchers Discover Treatment For Spinal Cord Injury Pain. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2006/11/061128084522.htm
American Academy of Neurology. "Researchers Discover Treatment For Spinal Cord Injury Pain." ScienceDaily. www.sciencedaily.com/releases/2006/11/061128084522.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins